Company news
Mymetics Corp. (OTC:MYMX) news
Mymetics Corp. news releases on 6ix. Latest, Aug 31, 2022: Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
Press releases & updates
Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
August 30, 2022
Mymetics to Advance Preclinical Studies for Virosome-based COVID-19 Vaccine through Innosuisse Grant
November 17, 2020
Mymetics Starts Second Preclinical Study for Virosome-based Covid-19 Vaccine
November 1, 2020
Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine
September 22, 2020
Mymetics Receives Support for Virosome-based Covid-19 Vaccine Development from European Vaccine Infrastructure Project (Transvac2)
June 10, 2020
Mymetics Reports Successful Preclinical Study Results with COP-Virosomes as Second-Generation Allergy Immunotherapy
May 27, 2020
Mymetics starts Research Project in Cancer Immunotherapy with IO Biotech
May 24, 2020
Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines
May 17, 2020
Mymetics Annouces Publication in Npj Vaccines of preclinical study of malaria vaccine
February 3, 2020
Mymetics Announces New Study to Predict Efficacy of Second- Generation COP Allergy Immunotherpy with Virosomes
October 16, 2019
Mymetics receives HIV Vaccine Funding from the NIH
April 29, 2019
Mymetics Receives Funding from NIH for Novel HIV Vaccine Study
April 28, 2019
Mymetics Virosomes Successful in Allergy Proof-of-Concept Study
December 12, 2018
Mymetics Presents New Data Regarding Cold Chain Independent Virosome Based Vaccines
November 13, 2018
Mymetics presents new data regarding cold chain independent virosome based vaccines
November 13, 2018
New Mymetics data to be presented by LMIV at American Society of Tropical Medicine and Hygiene
October 30, 2018
Mymetics Starts Research Collaboration Project in Cancer Immunotherapy with eTheRNA
October 15, 2018
New Mymetics Data Regarding Cold Chain Independent Virosome Based Vaccines to be Presented at AAPS in Washington, D.C.
October 10, 2018
New Mymetics data regarding cold chain independent virosome based vaccines to be presented at AAPS in Washington, D.C.
October 11, 2018
DGAP-News: Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy
April 22, 2018
Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy
April 22, 2018
Mymetics to Present New Preclinical Data on Thermostable and Cold-Chain Independent Virosome based Vaccines
September 13, 2017
Mymetics Starts Research Project with Sanofi for Influenza Vaccines
December 1, 2016
Mymetics and Texas Biomedical Research Institute Continue Collaboration on HIV Vaccine Development
September 19, 2016
Mymetics' HIV Vaccine Candidate Confirms Promise in Preclinical Study With the Texas Biomedical Research Institute
April 11, 2016
Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate
April 5, 2016
Mymetics Announces Discontinuation of the RSV Collaborative Project
January 28, 2016
OTC Markets Group Welcomes Newly Verified OTCQB Companies – Jan. 2
January 2, 2015
Mymetics Announces New Collaboration to Advance the Development of an Innovative Malaria Vaccine Candidate
November 18, 2014
Mymetics' Promising HIV Vaccine Candidate Obtains Funding to Begin Study at Texas Biomedical Research Institute
September 29, 2014